{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:46:22Z","timestamp":1782243982742,"version":"3.54.5"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T00:00:00Z","timestamp":1603584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T00:00:00Z","timestamp":1603584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10072-020-04808-5","type":"journal-article","created":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T08:02:38Z","timestamp":1603612958000},"page":"351-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Migraine neuroscience: from experimental models to target therapy"],"prefix":"10.1007","volume":"41","author":[{"given":"Rosaria","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Demartini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"De Icco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Putort\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,25]]},"reference":[{"issue":"1","key":"4808_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10194-019-1066-0","volume":"20","author":"AP Andreou","year":"2019","unstructured":"Andreou AP, Edvinsson L (2019) Mechanisms of migraine as a chronic evolutive condition. J Headache Pain 20(1):117","journal-title":"J Headache Pain"},{"issue":"8","key":"4808_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3598","volume":"48","author":"P Gormley","year":"2016","unstructured":"Gormley P, Anttila V, Winsvold BS et al (2016) Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 48(8):856\u2013866","journal-title":"Nat Genet"},{"issue":"3","key":"4808_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/WCO.0000000000000687","volume":"32","author":"I de Boer","year":"2019","unstructured":"de Boer I, van den Maagdenberg AMJM, Terwindt GM (2019) Advance in genetics of migraine. Curr Opin Neurol 32(3):413\u2013421","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"4808_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.22537","volume":"70","author":"C Mainero","year":"2011","unstructured":"Mainero C, Boshyan J, Hadjikhani N (2011) Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine. Ann Neurol 70(5):838\u2013845","journal-title":"Ann Neurol"},{"issue":"4","key":"4808_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/WNR.0b013e32801776bb","volume":"18","author":"AF Da Silva","year":"2007","unstructured":"Da Silva AF, Granziera C, Tuch DS, Snyder J, Vincent M, Hadjikhani N (2007) Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport. 18(4):301\u2013305","journal-title":"Neuroreport."},{"key":"4808_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1744-8069-7-71","volume":"7","author":"N Maleki","year":"2011","unstructured":"Maleki N, Becerra L, Nutile L, Pendse G, Brawn J, Bigal M, Burstein R, Borsook D (2011) Migraine attacks the basal ganglia. Mol Pain 7:71","journal-title":"Mol Pain"},{"issue":"1","key":"4808_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-14-65","volume":"14","author":"G Coppola","year":"2013","unstructured":"Coppola G, Di Lorenzo C, Schoenen J, Pierelli F (2013) Habituation and sensitization in primary headaches. J Headache Pain 14(1):65","journal-title":"J Headache Pain"},{"key":"4808_CR8","first-page":"445","volume":"39","author":"DW Dodick","year":"2019","unstructured":"Dodick DW (2019) CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications. Cephalalgia 2019 39:445\u2013458","journal-title":"Cephalalgia 2019"},{"issue":"3","key":"4808_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00210-006-0108-8","volume":"374","author":"S Mehrotra","year":"2006","unstructured":"Mehrotra S, Gupta S, Garrelds IM, Villal\u00f3n CM, Saxena PR, Bogers AJ, Maassenvandenbrink A (2006) Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery. Naunyn Schmiedebergs Arch Pharmacol 374(3):163\u2013175","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"4808_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(87)90112-9","volume":"142","author":"A Franco-Cereceda","year":"1987","unstructured":"Franco-Cereceda A, Rudehill A, Lundberg JM (1987) Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig. Eur J Pharmacol 142(2):235\u2013243","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4808_CR11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0703081","volume":"129","author":"I Bouchelet","year":"2000","unstructured":"Bouchelet I, Case B, Olivier A, Hamel E (2000) No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery. Br J Pharmacol 129(3):501\u2013508","journal-title":"Br J Pharmacol"},{"key":"4808_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2017.02.001","volume":"90","author":"M Sheykhzade","year":"2017","unstructured":"Sheykhzade M, Amandi N, Pla MV, Abdolalizadeh B, Sams A, Warfvinge K, Edvinsson L, Pickering DS (2017) Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries. Vascul Pharmacol 90:36\u201343","journal-title":"Vascul Pharmacol"},{"issue":"2\u20133","key":"4808_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejphar.2008.02.091","volume":"585","author":"A Maassenvandenbrink","year":"2008","unstructured":"Maassenvandenbrink A, Chan KY (2008) Neurovascular pharmacology of migraine. Eur J Pharmacol 585(2\u20133):313\u2013319","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"4808_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(99)00197-1","volume":"375","author":"P De Vries","year":"1999","unstructured":"De Vries P, Villal\u00f3n CM, Saxena PR (1999) Pharmacological aspects of experimental models in relation to acute antimigraine therapy. Eur J Pharmacol 375(1\u20133):61\u201374","journal-title":"Eur J Pharmacol"},{"key":"4808_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1468-2982.1997.1704525.x","volume":"17","author":"DJ Williamson","year":"1997","unstructured":"Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat\u2014intravital microscope studies. Cephalalgia 17:525\u2013531","journal-title":"Cephalalgia"},{"key":"4808_CR16","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/sj.bjp.0705896","volume":"142","author":"S Akerman","year":"2004","unstructured":"Akerman S, Kaube H, Goadsby PJ (2004) Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol 142:1354\u20131360","journal-title":"Br J Pharmacol"},{"key":"4808_CR17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.bjp.0705486","volume":"140","author":"S Akerman","year":"2003","unstructured":"Akerman S, Kaube H, Goadsby PJ (2003) Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol 140:718\u2013724","journal-title":"Br J Pharmacol"},{"issue":"11","key":"4808_CR18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/0333102419851810","volume":"39","author":"KA Haanes","year":"2019","unstructured":"Haanes KA, Labastida-Ram\u00edrez A, Blixt FW, Rubio-Beltr\u00e1n E, Dirven CM, Danser AH, Edvinsson L, MaassenVanDenBrink A (2019) Exploration of purinergic receptors aspotential anti-migraine targets using established pre-clinical migraine models. Cephalalgia 39(11):1421\u20131434","journal-title":"Cephalalgia"},{"issue":"6","key":"4808_CR19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.bjp.0705966","volume":"43","author":"KA Petersen","year":"2004","unstructured":"Petersen KA, Birk S, Doods H, Edvinsson L, Olesen J (2004) Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol 43(6):697\u2013704","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4808_CR20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/jcbfm.1992.70","volume":"12","author":"HE Connor","year":"1992","unstructured":"Connor HE, Stubbs CM, Feniuk W, Humphrey PP (1992) Effect of sumatriptan, a selective 5-HT1-like receptor agonist, on pial vessel diameter in anaesthetized cats. J Cereb Blood Flow Metab 12(3):514\u2013519","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20133","key":"4808_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2006.03.005","volume":"538","author":"L Juhl","year":"2006","unstructured":"Juhl L, Petersen KA, Larsen EH, Jansen-Olesen I, Olesen J (2006) The in vivo effect of adrenomedullin on rat dural and pial arteries. Eur J Pharmacol 538(1\u20133):101\u2013107","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4808_CR22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12031-014-0268-9","volume":"54","author":"X Wang","year":"2014","unstructured":"Wang X, Fang Y, Liang J, Yan M, Hu R, Pan X (2014) 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine. J Mol Neurosci 54(2):164\u2013170","journal-title":"J Mol Neurosci"},{"issue":"2","key":"4808_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0972-2327.182302","volume":"19","author":"R Malhotra","year":"2016","unstructured":"Malhotra R (2016) Understanding migraine: potential role of neurogenic inflammation. Ann Indian Acad Neurol 19(2):175\u2013182","journal-title":"Ann Indian Acad Neurol"},{"key":"4808_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fncel.2015.00287","volume":"9","author":"A Zakharov","year":"2015","unstructured":"Zakharov A, Vitale C, Kilinc E, Koroleva K, Fayuk D, Shelukhina I, Naumenko N, Skorinkin A, Khazipov R, Giniatullin R (2015) Hunting for origins of migraine pain: cluster analysis of spontaneous and capsaicin-induced firing in meningeal trigeminal nerve fibers. Front Cell Neurosci 9:287","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"4808_CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3940(94)11203-U","volume":"184","author":"E Knyihar-Csillik","year":"1995","unstructured":"Knyihar-Csillik E, Tajti J, Mohtasham S, Sari G, Vecsei L (1995) Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: a possible model of migraine headache. Neurosci Lett 184(3):189\u2013192","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"4808_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(00)00475-9","volume":"92","author":"V Limmroth","year":"2001","unstructured":"Limmroth V, Katsarava Z, Liedert B, Guehring H, Schmitz K, Diener HC, Michel MC (2001) An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain 92(1\u20132):101\u2013106","journal-title":"Pain"},{"key":"4808_CR27","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1523\/JNEUROSCI.07-12-04129.1987","volume":"7","author":"S Markowitz","year":"1987","unstructured":"Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129\u20134136","journal-title":"J Neurosci"},{"key":"4808_CR28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1476-5381.1990.tb14679.x","volume":"99","author":"MG Buzzi","year":"1990","unstructured":"Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99:202\u2013206","journal-title":"Br J Pharmacol"},{"issue":"5","key":"4808_CR29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-4547(19970601)48:5<449::AID-JNR6>3.0.CO;2-E","volume":"48","author":"E Knyihar-Csillik","year":"1997","unstructured":"Knyihar-Csillik E et al (1997) Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model. J Neurosci Res 48(5):449\u2013464","journal-title":"J Neurosci Res"},{"issue":"9","key":"4808_CR30","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s10072-013-1292-1","volume":"34","author":"Z Boh\u00e1r","year":"2013","unstructured":"Boh\u00e1r Z, Fejes-Szab\u00f3 A, Tar L, Varga H, Tajti J, P\u00e1rdutz \u00c1, V\u00e9csei L (2013) Evaluation of c-Fos immunoreactivity in the rat brainstem nuclei relevant in migraine pathogenesis after electrical stimulation of the trigeminal ganglion. Neurol Sci 34(9):1597\u20131604","journal-title":"Neurol Sci"},{"key":"4808_CR31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0028-3908(91)90165-8","volume":"30","author":"MG Buzzi","year":"1991","unstructured":"Buzzi MG, Carter WB, Shimizu T, Heath H III, Moskowitz MA (1991) Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30:1193\u20131200","journal-title":"Neuropharmacology"},{"key":"4808_CR32","doi-asserted-by":"crossref","first-page":"174480691882045","DOI":"10.1177\/1744806918820452","volume":"15","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Han X, Wu H, Zhang M, Hu G, Dong Z, Yu S (2019) Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: relevant to migraine. Mol Pain 15:1744806918820452","journal-title":"Mol Pain"},{"key":"4808_CR33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fneur.2017.00745","volume":"8","author":"T K\u00f6rt\u00e9si","year":"2018","unstructured":"K\u00f6rt\u00e9si T, Tuka B, Tajti J, Bagoly T, F\u00fcl\u00f6p F, Helyes Z, V\u00e9csei L (2018) Kynurenic acid inhibits the electrical stimulation induced elevated pituitary adenylate cyclase-activating polypeptide expression in the TNC. Front Neurol 8:745","journal-title":"Front Neurol"},{"key":"4808_CR34","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1476-5381.1988.tb11630.x","volume":"94","author":"PP Humphrey","year":"1988","unstructured":"Humphrey PP, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates LH, Butina D (1988) GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol 94:1123\u20131132","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4808_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0143-4179(90)90114-E","volume":"16","author":"AS Zagami","year":"1990","unstructured":"Zagami AS, Goadsby PJ, Edvinsson L (1990) Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16(2):69\u201375","journal-title":"Neuropeptides"},{"issue":"20","key":"4808_CR36","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1523\/JNEUROSCI.0439-13.2013","volume":"33","author":"C Robert","year":"2013","unstructured":"Robert C, Bourgeais L, Arreto CD, Condes-Lara M, Noseda R, Jay T, Villanueva L (2013) Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches. J Neurosci 33(20):8827\u20138840","journal-title":"J Neurosci"},{"issue":"4","key":"4808_CR37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.23653","volume":"72","author":"PR Holland","year":"2012","unstructured":"Holland PR, Akerman S, Andreou AP, Karsan N, Wemmie JA, Goadsby PJ (2012) Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura. Ann Neurol 72(4):559\u2013563","journal-title":"Ann Neurol"},{"issue":"1","key":"4808_CR38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(93)90486-7","volume":"629","author":"H Kaube","year":"1993","unstructured":"Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ (1993) Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629(1):95\u2013102","journal-title":"Brain Res"},{"issue":"2","key":"4808_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1468-1331.1994.tb00062.x","volume":"1","author":"H Kaube","year":"1994","unstructured":"Kaube H, Hoskin KL, Goadsby PJ (1994) Acetylsalicylic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat. Eur J Neurol 1(2):141\u2013146","journal-title":"Eur J Neurol"},{"key":"4808_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(99)00025-1","volume":"82","author":"PJ Goadsby","year":"1999","unstructured":"Goadsby PJ, Hoskin KL (1999) Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat. Pain 82:15\u201322","journal-title":"Pain"},{"key":"4808_CR41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exnr.1997.6749","volume":"150","author":"KL Hoskin","year":"1998","unstructured":"Hoskin KL, Goadsby PJ (1998) Comparison of a more and less lipophilic serotonin (5HT1B\/1D) agonist in a model of trigeminovascular nociception in cat. Exp Neurol 150:45\u201351","journal-title":"Exp Neurol"},{"key":"4808_CR42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1476-5381.1995.tb13361.x","volume":"114","author":"M Kurosawa","year":"1995","unstructured":"Kurosawa M, Messlinger K, Pawlak M, Schmidt RF (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114:1397\u20131402","journal-title":"Br J Pharmacol"},{"key":"4808_CR43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-2999(97)01072-8","volume":"332","author":"K Messlinger","year":"1997","unstructured":"Messlinger K, Hotta H, Pawlak M, Schmidt RF (1997) Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat. Eur J Pharmacol 332:173\u2013181","journal-title":"Eur J Pharmacol"},{"key":"4808_CR44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(98)00051-7","volume":"76","author":"DD Mitsikostas","year":"1998","unstructured":"Mitsikostas DD, Sanchez del Rio M, Waeber C, Moskowitz MA, Cutrer FM (1998) The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis. Pain 76:239\u2013248","journal-title":"Pain"},{"key":"4808_CR45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1526-4610.1999.3910697.x","volume":"39","author":"FM Cutrer","year":"1999","unstructured":"Cutrer FM, Mitsikostas DD, Ayata G, Sanchez del Rio M (1999) Attenuation by butalbital of capsaicin-induced c-fos-like immunoreactivity in trigeminal nucleus caudalis. Headache 39:697\u2013704","journal-title":"Headache"},{"issue":"35","key":"4808_CR46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-0173(00)00048-5","volume":"2001","author":"DD Mitsikostas","year":"2001","unstructured":"Mitsikostas DD, Sanchez del Rio M (2001) Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Rev 2001(35):20\u201335","journal-title":"Brain Res Rev"},{"key":"4808_CR47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(00)00478-4","volume":"89","author":"R Burstein","year":"2001","unstructured":"Burstein R (2001) Deconstructing migraine headache into peripheral and central sensitization. Pain 89:107\u2013110","journal-title":"Pain"},{"issue":"1","key":"4808_CR48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-020-01169-4","volume":"21","author":"KF Laborc","year":"2020","unstructured":"Laborc KF, Spekker E, Boh\u00e1r Z, Sz\u0171cs M, Nagy-Gr\u00f3cz G, Fejes-Szab\u00f3 A, V\u00e9csei L, P\u00e1rdutz \u00c1 (2020) Trigeminal activation patterns evoked by chemical stimulation of the dura mater in rats. J Headache Pain 21(1):101","journal-title":"J Headache Pain"},{"key":"4808_CR49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2017.02.001","volume":"1660","author":"L Becerra","year":"2017","unstructured":"Becerra L, Bishop J, Barmettler G, Kainz V, Burstein R, Borsook D (2017) Brain network alterations in the inflammatory soup animal model of migraine. Brain Res 1660:36\u201346","journal-title":"Brain Res"},{"issue":"65","key":"4808_CR50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.21537","volume":"2009","author":"RM Edelmayer","year":"2009","unstructured":"Edelmayer RM, Vanderah TW, Majuta L, Zhang ET, Fioravanti B, de Felice M, Chichorro JG, Ossipov MH, King T, Lai J, Kori SH, Nelsen AC, Cannon KE, Heinricher MM, Porreca F (2009) Medullary pain facilitating neurons mediate allodynia in headache-related pain. Ann Neurol 2009(65):184\u2013193","journal-title":"Ann Neurol"},{"issue":"1","key":"4808_CR51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0333102418779557","volume":"39","author":"CC Burgos-Vega","year":"2019","unstructured":"Burgos-Vega CC, Quigley LD, Trevisan Dos Santos G, Yan F, Asiedu M, Jacobs B, Motina M, Safdar N, Yousuf H, Avona A, Price TJ, Dussor G (2019) Non-invasive dural stimulation in mice: a novel preclinical model of migraine. Cephalalgia. 39(1):123\u2013134","journal-title":"Cephalalgia."},{"issue":"10","key":"4808_CR52","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/j.pain.0000000000001007","volume":"158","author":"N Boyer","year":"2017","unstructured":"Boyer N, Signoret-Genest J, Artola A, Dallel R, Monconduit L (2017) Propranolol treatment prevents chronic central sensitization induced by repeated dural stimulation. Pain. 158(10):2025\u20132034","journal-title":"Pain."},{"issue":"1","key":"4808_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-017-0736-z","volume":"18","author":"M Zhang","year":"2017","unstructured":"Zhang M, Liu Y, Zhao M, Tang W, Wang X, Dong Z, Yu S (2017) Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain 18(1):27","journal-title":"J Headache Pain"},{"issue":"1","key":"4808_CR54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1673-5374.243715","volume":"14","author":"N Chen","year":"2019","unstructured":"Chen N, Su W, Cui SH, Guo J, Duan JC, Li HX, He L (2019) A novel large animal model of recurrent migraine established by repeated administration of inflammatory soup into the dura mater of the rhesus monkey. Neural Regen Res 14(1):100\u2013106","journal-title":"Neural Regen Res"},{"issue":"8","key":"4808_CR55","first-page":"540","volume":"33","author":"M Ashina","year":"2013","unstructured":"Ashina M, Hansen JM, Olesen J (2013) Pearls and pitfalls in human pharmacological models of migraine: 30 years\u2019 experience. Cephalalgia 2013 33(8):540\u2013553","journal-title":"Cephalalgia 2013"},{"key":"4808_CR56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2019.02.002","volume":"177","author":"C Demartini","year":"2019","unstructured":"Demartini C, Greco R, Zanaboni AM, Sances G, De Icco R, Borsook D, Tassorelli C (2019) Nitroglycerin as a comparative experimental model of migraine pain: from animal to human and back. Prog Neurobiol 177:15\u201332","journal-title":"Prog Neurobiol"},{"issue":"2","key":"4808_CR57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10194-010-0274-4","volume":"12","author":"R Greco","year":"2011","unstructured":"Greco R, Mangione AS, Sandrini G, Maccarrone M, Nappi G, Tassorelli C (2011) Effects of anandamide in migraine: data from an animal model. J Headache Pain 12(2):177\u2013183","journal-title":"J Headache Pain"},{"issue":"2","key":"4808_CR58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","volume":"155","author":"AA Pradhan","year":"2014","unstructured":"Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, Charles A (2014) Characterization of a novel model of chronic migraine. Pain 155(2):269\u2013274","journal-title":"Pain"},{"issue":"2","key":"4808_CR59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-2982.2009.01864.x","volume":"30","author":"EA Bates","year":"2010","unstructured":"Bates EA, Nikai T, Brennan KC, Fu YH, Charles AC, Basbaum AI, Pt\u00e1cek LJ, Ahn AH (2010) Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. Cephalalgia 30(2):170\u2013178","journal-title":"Cephalalgia"},{"issue":"12","key":"4808_CR60","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102414566862","volume":"35","author":"R Greco","year":"2015","unstructured":"Greco R, Bandiera T, Mangione AS, Demartini C, Siani F, Nappi G, Sandrini G, Guijarro A, Armirotti A, Piomelli D, Tassorelli C (2015) Effects of peripheral FAAH blockade on NTG-induced hyperalgesia--evaluation of URB937 in an animal model of migraine. Cephalalgia. 35(12):1065\u20131076","journal-title":"Cephalalgia."},{"key":"4808_CR61","first-page":"333102420942230","volume":"26","author":"R De Icco","year":"2020","unstructured":"De Icco R, Fiamingo G, Greco R, Bottiroli S, Demartini C, Zanaboni AM, Allena M, Guaschino E, Martinelli D, Putort\u00ec A, Grillo V, Sances G, Tassorelli C (2020) Neurophysiological and biomolecular effects of erenumab in chronic migraine: an open label study. Cephalalgia. 26:333102420942230","journal-title":"Cephalalgia."},{"issue":"1","key":"4808_CR62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s10194-018-0879-6","volume":"19","author":"R Greco","year":"2018","unstructured":"Greco R, Demartini C, Zanaboni AM, Tassorelli C (2018) Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing. J Headache Pain 19(1):51","journal-title":"J Headache Pain"},{"issue":"1\u20132","key":"4808_CR63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2005.05.067","volume":"1051","author":"C Tassorelli","year":"2005","unstructured":"Tassorelli C, Greco R, Cappelletti D, Sandrini G, Nappi G (2005) Comparative analysis of the neuronal activation and cardiovascular effects of nitroglycerin, sodium nitroprusside and L-arginine. Brain Res 1051(1\u20132):17\u201324","journal-title":"Brain Res"},{"issue":"4","key":"4808_CR64","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1468-2982.2008.01745.x","volume":"29","author":"S Koulchitsky","year":"2009","unstructured":"Koulchitsky S, Fischer MJ, Messlinger K (2009) Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus. Cephalalgia. 29(4):408\u2013417","journal-title":"Cephalalgia."},{"issue":"11","key":"4808_CR65","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1097\/j.pain.0000000000001337","volume":"159","author":"BJ Rea","year":"2018","unstructured":"Rea BJ, Wattiez AS, Waite JS, Castonguay WC, Schmidt CM, Fairbanks AM, Robertson BR, Brown CJ, Mason BN, Moldovan-Loomis MC, Garcia-Martinez LF, Poolman P, Ledolter J, Kardon RH, Sowers LP, Russo AF (2018) Peripherally administered calcitonin gene-related peptide induces spontaneous pain in mice: implications for migraine. Pain. 159(11):2306\u20132317","journal-title":"Pain."},{"issue":"1","key":"4808_CR66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10194-019-0968-1","volume":"20","author":"F De Logu","year":"2019","unstructured":"De Logu F, Landini L, Janal MN et al (2019) Migraine-provoking substances evoke periorbital allodynia in mice. J Headache Pain 20(1):18","journal-title":"J Headache Pain"},{"issue":"1","key":"4808_CR67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1523\/JNEUROSCI.2967-16.2016","volume":"37","author":"BN Mason","year":"2017","unstructured":"Mason BN, Kaiser EA, Kuburas A, Loomis MCM, Latham JA, Garcia-Martinez LF, Russo AF (2017) Induction of migraine-like photophobic behavior in mice by both peripheral and central CGRP mechanisms. J Neurosci 37(1):204\u2013216","journal-title":"J Neurosci"},{"key":"4808_CR68","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/sj.bjp.0702444","volume":"126","author":"MJ Cumberbatch","year":"1999","unstructured":"Cumberbatch MJ, Williamson DJ, Mason GS, Hill RG, Hargreaves RJ (1999) Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B\/1D agonist. Br J Pharmacol 126:1478\u20131486","journal-title":"Br J Pharmacol"},{"key":"4808_CR69","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.20619","volume":"58","author":"D Levy","year":"2005","unstructured":"Levy D, Burstein R, Strassman AM (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58:698\u2013705","journal-title":"Ann Neurol"},{"key":"4808_CR70","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0333102414535995","volume":"35","author":"DK Bhatt","year":"2015","unstructured":"Bhatt DK, Ramachandran R, Christensen SL, Gupta S, Jansen-Olesen I, Olesen J (2015) CGRP infusion in unanesthetized rats increases expression of c-Fos in the nucleus tractus solitarius and caudal ventrolateral medulla, but not in the trigeminal nucleus caudalis. Cephalalgia 35:220\u2013233","journal-title":"Cephalalgia"},{"issue":"308","key":"4808_CR71","doi-asserted-by":"crossref","first-page":"308ra157","DOI":"10.1126\/scitranslmed.aaa7557","volume":"7","author":"S Akerman","year":"2015","unstructured":"Akerman S, Goadsby PJ (2015) Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: relevance to migraine. Sci Transl Med 7(308):308ra157","journal-title":"Sci Transl Med"},{"key":"4808_CR72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2019.00114","volume":"13","author":"SH Pedersen","year":"2019","unstructured":"Pedersen SH, la Cour SH, Calloe K, Hauser F, Olesen J, Klaerke DA, Jansen-Olesen I (2019) PACAP-38 and PACAP (6-38) Degranulate rat meningeal mast cells via the orphan MrgB3-receptor. Front Cell Neurosci 13:114","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"4808_CR73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1129-2377-14-62","volume":"14","author":"C Costa","year":"2013","unstructured":"Costa C, Tozzi A, Rainero I, Cupini LM, Calabresi P, Ayata C, Sarchielli P (2013) Cortical spreading depression as a target for anti-migraine agents. J Headache Pain 14(1):62","journal-title":"J Headache Pain"},{"issue":"46","key":"4808_CR74","doi-asserted-by":"crossref","first-page":"18985","DOI":"10.1073\/pnas.1215435109","volume":"109","author":"A Tozzi","year":"2012","unstructured":"Tozzi A, de Iure A, Di Filippo M et al (2012) Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. Proc Natl Acad Sci U S A 109(46):18985\u201318990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4808_CR75","first-page":"206","volume":"481","author":"I Jansen-Olesen","year":"2013","unstructured":"Jansen-Olesen I, Jorgensen L, Engel U, Edvinsson L (2013) In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol 481:206\u2013217","journal-title":"Eur J Pharmacol"},{"key":"4808_CR76","doi-asserted-by":"crossref","unstructured":"Edvinsson L, Gulbenkian S, Barroso CP, Cunha e S\u00e1 M, Polak JM, Mortensen A, J\u00f8rgensen L, Jansen-Olesen I (1998) Innervation of the human middle meningeal artery:immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides 19(7):1213\u20131225","DOI":"10.1016\/S0196-9781(98)00066-7"},{"issue":"6","key":"4808_CR77","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","volume":"60","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60(6):1259\u20131287","journal-title":"Drugs"},{"key":"4808_CR78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01532-1","volume":"434","author":"L Edvinsson","year":"2002","unstructured":"Edvinsson L, Alm R, Shaw D, Rutledge RZ, Koblan KS, Longmore J, Kane SA (2002) Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur J Pharmacol 434:49\u201355","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4808_CR79","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1526-4610.1987.hed2704180.x","volume":"27","author":"F Sicuteri","year":"1987","unstructured":"Sicuteri F, Del Bene E, Poggioni M, Bonazzi A (1987) Unmasking latent dysnociception in healthy subjects. Headache 27(4):180\u2013185","journal-title":"Headache"},{"issue":"2","key":"4808_CR80","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1468-2982.2004.00639.x","volume":"24","author":"G Sances","year":"2004","unstructured":"Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G (2004) Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia 24(2):110\u2013119","journal-title":"Cephalalgia"},{"issue":"1","key":"4808_CR81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(89)90067-5","volume":"38","author":"HK Iversen","year":"1989","unstructured":"Iversen HK, Olesen J, Tfelt-Hansen P (1989) Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38(1):17\u201324","journal-title":"Pain"},{"key":"4808_CR82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/164_2018_128","volume":"255","author":"H Ashina","year":"2019","unstructured":"Ashina H, Schytz HW, Ashina M (2019) CGRP in Human Models of Migraine. Handb Exp Pharmacol 255:109\u2013120","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"4808_CR83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s10194-017-0821-3","volume":"18","author":"H Ashina","year":"2017","unstructured":"Ashina H, Guo S, Vollesen ALH, Ashina M (2017) PACAP38 in human models of primary headaches. J Headache Pain 18(1):110","journal-title":"J Headache Pain"},{"key":"4808_CR84","doi-asserted-by":"crossref","unstructured":"Falkenberg K, R\u00f8nde Bjerg H, Yamani N, Olesen J (2020) Sumatriptan does not antagonize CGRP-induced symptoms in healthy volunteers. Headache 60(4):665\u2013676","DOI":"10.1111\/head.13747"},{"key":"4808_CR85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-2982.2007.01497.x","volume":"28","author":"A Rahmann","year":"2008","unstructured":"Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226\u2013236","journal-title":"Cephalalgia"},{"key":"4808_CR86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16\u201325","journal-title":"Brain"},{"issue":"8","key":"4808_CR87","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp.2004.050633","volume":"76","author":"S Afridi","year":"2005","unstructured":"Afridi S, Kaube H, Goadsby PJ (2005) Occipital activation in glyceryl trinitrate induced migraine with visual aura. J Neurol Neurosurg Psychiatry 76(8):1158\u20131160","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"4808_CR88","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0b013e3181cff79d","volume":"74","author":"JM Hansen","year":"2010","unstructured":"Hansen JM, Thomsen LL, Olesen J, Ashina M (2010) Coexisting typical migraine in familial hemiplegic migraine. Neurology 74(7):594\u2013600","journal-title":"Neurology"},{"issue":"4","key":"4808_CR89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.22292","volume":"69","author":"MS Asghar","year":"2011","unstructured":"Asghar MS, Hansen AE, Amin FM, van der Geest RJ, Koning Pv, Larsson HB, Olesen J, Ashina M (2011) Evidence for a vascular factor in migraine. Ann Neurol 69(4):635\u2013645","journal-title":"Ann Neurol"},{"issue":"4","key":"4808_CR90","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1468-1331.2000.00094.x","volume":"7","author":"I Christiansen","year":"2000","unstructured":"Christiansen I, Daugaard D, Lykke Thomsen L, Olesen J (2000) Glyceryl trinitrate induced headache in migraineurs - relation to attack frequency. Eur J Neurol 7(4):405\u2013411","journal-title":"Eur J Neurol"},{"issue":"3","key":"4808_CR91","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.pain.2004.05.007","volume":"110","author":"SK Afridi","year":"2004","unstructured":"Afridi SK, Kaube H, Goadsby PJ (2004) Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 110(3):675\u2013680","journal-title":"Pain"},{"issue":"1","key":"4808_CR92","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1129-2377-15-84","volume":"15","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Schankin C, Goadsby PJ (2014) The origin of nausea in migraine-a PET study. J Headache Pain 15(1):84","journal-title":"J Headache Pain"},{"issue":"12","key":"4808_CR93","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","volume":"157","author":"S Guo","year":"2016","unstructured":"Guo S, Vollesen AL, Olesen J, Ashina M (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain 157(12):2773\u20132781","journal-title":"Pain"},{"issue":"2","key":"4808_CR94","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1468-2982.2003.00465.x","volume":"23","author":"JN de Hoon","year":"2003","unstructured":"de Hoon JN, Willigers JM, Troost J, Struijker-Boudier HA, van Bortel LM (2003) Cranial and peripheral interictal vascular changes in migraine patients. Cephalalgia 23(2):96\u2013104","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"4808_CR95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2009.04.018","volume":"144","author":"L Di Clemente","year":"2009","unstructured":"Di Clemente L, Coppola G, Magis D, G\u00e9rardy PY, Fumal A, De Pasqua V, Di Piero V, Schoenen J (2009) Nitroglycerin sensitises in healthy subjects CNS structures involved in migraine pathophysiology: evidence from a study of nociceptive blink reflexes and visual evoked potentials. Pain 144(1\u20132):156\u2013161","journal-title":"Pain"},{"issue":"5","key":"4808_CR96","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejpain.2010.09.010","volume":"15","author":"A Perrotta","year":"2011","unstructured":"Perrotta A, Serrao M, Tassorelli C, Arce-Leal N, Guaschino E, Sances G, Rossi P, Bartolo M, Pierelli F, Sandrini G, Nappi G (2011) Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study. Eur J Pain 15(5):482\u2013490","journal-title":"Eur J Pain"},{"key":"4808_CR97","doi-asserted-by":"crossref","unstructured":"Asghar MS, Becerra L, Larsson HB, Borsook D, Ashina M (2016) Calcitonin gene- related peptide modulates heat nociception in the human brain - an fmri study in healthy volunteers. PLoS One 11(3):e0150334","DOI":"10.1371\/journal.pone.0150334"},{"issue":"7","key":"4808_CR98","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1468-2982.2003.00720.x","volume":"24","author":"JF Tvedskov","year":"2004","unstructured":"Tvedskov JF, Thomsen LL, Iversen HK, Gibson A, Wiliams P, Olesen J (2004) The prophylactic effect of valproate on glyceryltrinitrate induced migraine. Cephalalgia 24(7):576\u2013585","journal-title":"Cephalalgia"},{"issue":"1","key":"4808_CR99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/00912709922007525","volume":"39","author":"T Fullerton","year":"1999","unstructured":"Fullerton T, Komorowski-Swiatek D, Forrest A, Gengo FM (1999) The pharmacodynamics of sumatriptan in nitroglycerin-induced headache. J Clin Pharmacol 39(1):17\u201329","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"4808_CR100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1365-2125.2010.03869.x","volume":"71","author":"BJ Van der Schueren","year":"2011","unstructured":"Van der Schueren BJ, Blanchard R, Murphy MG, Palcza J, De Lepeleire I, Van Hecken A, Depr\u00e9 M, de Hoon JN (2011) The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men. Br J Clin Pharmacol 71(5):708\u2013717","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"4808_CR101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1468-2982.2004.00830.x","volume":"25","author":"KA Petersen","year":"2005","unstructured":"Petersen KA, Birk S, Lassen LH, Kruuse C, Jonassen O, Lesko L, Olesen J (2005) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 25(2):139\u2013147","journal-title":"Cephalalgia"},{"key":"4808_CR102","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.nbd.2019.104624","volume":"134","author":"R Greco","year":"2020","unstructured":"Greco R, Demartini C, Zanaboni AM, Tumelero E, Reggiani A, Misto A, Piomelli D, Tassorelli C (2020) FAAH inhibition as a preventive treatment for migraine: A pre-clinical study. Neurobiol Dis 134:104624","journal-title":"Neurobiol Dis"},{"issue":"36","key":"4808_CR103","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.0503264102","volume":"102","author":"JS Mogil","year":"2005","unstructured":"Mogil JS, Miermeister F, Seifert F, Strasburg K, Zimmermann K, Reinold H, Austin JS, Bernardini N, Chesler EJ, Hofmann HA, Hordo C, Messlinger K, Nemmani KV, Rankin AL, Ritchie J, Siegling A, Smith SB, Sotocinal S, Vater A, Lehto SG, Klussmann S, Quirion R, Michaelis M, Devor M, Reeh PW (2005) Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci USA 102(36):12938\u201312943","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"4808_CR104","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjp.0703502","volume":"130","author":"DQ Chu","year":"2000","unstructured":"Chu DQ, Choy M, Foster P, Cao T, Brain SD (2000) A comparative study of the ability of calcitonin generelated peptide and adrenomedullin (13\u201352) to modulate microvascular but not thermal hyperalgesia responses. Br J Pharmacol 130(7):1589\u20131596","journal-title":"Br J Pharmacol"},{"issue":"9","key":"4808_CR105","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jpain.2009.03.018","volume":"10","author":"B Marquez de Prado","year":"2009","unstructured":"Marquez de Prado B, Hammond DL, Russo AF (2009) Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice. J Pain 10(9):992\u20131000","journal-title":"J Pain"},{"issue":"1","key":"4808_CR106","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0006-8993(00)02473-2","volume":"873","author":"Y Huang","year":"2004","unstructured":"Huang Y, Brodda-Jansen G, Lundeberg T, Yu LC (2004) Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone. Brain Res 873(1):54\u201359","journal-title":"Brain Res"},{"key":"4808_CR107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2017.04.059","volume":"651","author":"G Yao","year":"2017","unstructured":"Yao G, Huang Q, Wang M, Yang CL, Liu CF, Yu TM (2017) Behavioral study of a rat model of migraine induced by CGRP. Neurosci Lett 651:134\u2013139","journal-title":"Neurosci Lett"},{"issue":"14","key":"4808_CR108","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1177\/0333102419861726","volume":"39","author":"SL Christensen","year":"2019","unstructured":"Christensen SL, Petersen S, Kristensen DM, Olesen J, Munro G (2019) Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain. Cephalalgia 39(14):1827\u20131837","journal-title":"Cephalalgia"},{"issue":"8","key":"4808_CR109","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0333102413517776","volume":"34","author":"R Greco","year":"2014","unstructured":"Greco R, Mangione AS, Siani F, Blandini F, Vairetti M, Nappi G, Sandrini G, Buzzi MG, Tassorelli C (2014) Effects of CGRP receptor antagonism in nitroglycerin-induced hyperalgesia. Cephalalgia 34(8):594\u2013604","journal-title":"Cephalalgia"},{"issue":"21","key":"4808_CR110","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1111\/bph.14053","volume":"175","author":"T Sundrum","year":"2018","unstructured":"Sundrum T, Walker CS (2018) Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine. Br J Pharmacol 175(21):4109\u20134120","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4808_CR111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.118.253443","volume":"369","author":"C Moldovan Loomis","year":"2019","unstructured":"Moldovan Loomis C, Dutzar B, Ojala EW, Hendrix L, Karasek C, Scalley-Kim M, Mulligan J, Fan P, Billgren J, Rubin V, Boshaw H, Kwon G, Marzolf S, Stewart E, Jurchen D, Pederson SM, Perrino McCulloch L, Baker B, Cady RK, Latham JA, Allison D, Garcia-Martinez LF (2019) Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase- Activating Peptide. J Pharmacol Exp Ther 369(1):26\u201336","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4808_CR112","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s10194-017-0804-4","volume":"18","author":"C Demartini","year":"2017","unstructured":"Demartini C, Tassorelli C, Zanaboni AM, Tonsi G, Francesconi O, Nativi C, Greco R (2017) The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model. J Headache Pain 18(1):94","journal-title":"J Headache Pain"},{"issue":"10","key":"4808_CR113","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1096\/fj.201800272R","volume":"32","author":"E Mirrasekhian","year":"2018","unstructured":"Mirrasekhian E, Nilsson JL\u00c5, Shionoya K, Blomgren A, Zygmunt PM, Engblom D, H\u00f6gest\u00e4tt ED, Blomqvist A (2018) The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain. FASEB J 32(10):5751\u20135759","journal-title":"FASEB J"},{"key":"4808_CR114","doi-asserted-by":"crossref","unstructured":"Vila-Pueyo M (2018) Targeted 5-HT1F Therapies for Migraine. Neurotherapeutics 15(2):291\u2013303","DOI":"10.1007\/s13311-018-0615-6"},{"issue":"5","key":"4808_CR115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","volume":"63","author":"RG Pertwee","year":"2001","unstructured":"Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63(5):569\u2013611","journal-title":"Prog Neurobiol"},{"issue":"9","key":"4808_CR116","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0333102420938652","volume":"40","author":"E Navratilova","year":"2020","unstructured":"Navratilova E, Behravesh S, Oyarzo J, Dodick DW, Banerjee P, Porreca F (2020) Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia 40(9):892\u2013902","journal-title":"Cephalalgia"},{"issue":"9","key":"4808_CR117","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/brain\/awaa211","volume":"143","author":"C Saengjaroentham","year":"2020","unstructured":"Saengjaroentham C, Strother LC, Dripps I, Sultan Jabir MR, Pradhan A, Goadsby PJ, Holland PR (2020) Differential medication overuse risk of novel anti-migraine therapeutics. Brain 143(9):2681\u20132688","journal-title":"Brain"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04808-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04808-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04808-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T09:35:29Z","timestamp":1635240929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04808-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,25]]},"references-count":117,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4808"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04808-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,25]]},"assertion":[{"value":"25 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CT received honoraria for the participation to advisory boards or for oral presentations from 424 Allergan, ElectroCore, Eli-Lilly, Novartis, and Teva. CT has no ownership interest and does not 425 own stocks of any pharmaceutical company. CT serves as Chief Section Editor of Frontiers in 426 Neurology\u2014Section Headache Medicine and Facial Pain and on the editorial board of The Journal of Headache and Pain.The other authors have no potential conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any study with human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}